image
Healthcare - Biotechnology - NASDAQ - US
$ 2.055
-1.43 %
$ 6.48 M
Market Cap
-0.42
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
189.43%
EBIT Estimate
67.45%
Net Income Estimate
42.13%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Soligenix, Inc.
image
SNGX has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart SNGX

image
$12.0m$12.0m$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.020152015201620162017201720182018201920192020202020212021202220222023202320242024202520252026202620272027
EBIT FORECAST

EBIT Forecast Chart SNGX

image
$0.0$0.0($2.0m)($2.0m)($4.0m)($4.0m)($6.0m)($6.0m)($8.0m)($8.0m)($10.0m)($10.0m)($12.0m)($12.0m)($14.0m)($14.0m)($16.0m)($16.0m)($18.0m)($18.0m)($20.0m)($20.0m)20152015201620162017201720182018201920192020202020212021202220222023202320242024202520252026202620272027
NET INCOME FORECAST

Net Income Chart SNGX

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)20152015201620162017201720182018201920192020202020212021202220222023202320242024202520252026202620272027